Indiana · 90739

Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use in Indiana

Indiana Medicare Avg
$140.70
4% below national avg
National Medicare Avg
$146.78
All states combined
Billed Charge (IN)
$221.64
What providers submit
Est. Commercial (IN)
$295.47
National avg: $328.79
Est. Cash / Self-Pay (IN)
$166.48
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

365
Services in IN
152
Providers
N/A
Min Payment
N/A
Max Payment

Indiana Pricing in Context

In Indiana, CPT code 90739 (Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use) carries an average Medicare payment of $140.70 — 4% below the national benchmark of $146.78. 152 providers across the state submitted claims for this procedure in 2023, performing 365 total services. Individual payments in IN ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Indiana is $221.64, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Indiana sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Vaccines & Injections procedures, the estimated commercial insurance price in Indiana lands near $295.47, with self-pay cash prices typically around $166.48. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use cost in Indiana?

The average Medicare payment for Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use in Indiana is $140.70, which is 4% below the national average of $146.78. Providers in IN typically bill $221.64 for this procedure.

What does Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use cost with insurance in Indiana?

With commercial insurance in Indiana, Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use costs an estimated $295.47. Without insurance, the estimated cash price is $166.48. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use in Indiana?

152 providers in Indiana billed Medicare for Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use in 2023, performing 365 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use cheaper in Indiana than the national average?

Yes — Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use costs 4% below the national average in Indiana. The state average Medicare payment is $140.70 compared to $146.78 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial